Heart Valve Disorder Guidance -Expert Online Cardiology Consultation

About 1–2% of people are born with only two aortic valve leaflets instead of three. This bicuspid valve works fine for decades, but tends to calcify and stiffen in the early 50s — earlier than most patients or their doctors expect. I have lost count of how many patients I've seen who were told for years, “it's just a murmur,” only to finally get a proper echo and discover significant aortic stenosis from an undiagnosed bicuspid valve.

BAV is also an aorta problem, not just a valve problem. Up to 80% of BAV patients have some degree of aortic root or ascending aorta dilation. The 2022 ACC/AHA guidelines recommend lifelong aortic surveillance and screening of all first-degree relatives. An ascending aorta ≥4.5 cm in a BAV patient requires urgent specialist evaluation.

This is calcium slowly narrowing a normal three-leaflet valve over decades — affecting nearly 10% of people in their 80s. Until recently, the only option was open-heart surgery. That changed with TAVR (Transcatheter Aortic Valve Replacement): a new valve delivered through a catheter in the groin, no chest incision required. Seven-year data from the PARTNER 3 trial (NEJM 2025) and five-year data from the Evolut Low Risk trial (JACC 2025) confirm TAVR outcomes are comparable to surgery even in low-risk patients — transformative for elderly and frail patients who previously had no good options.

Mitral valve prolapse affects 2–3% of the population. Most people live with it uneventfully for life. But when it progresses to significant leakage (mitral regurgitation), the heart begins to strain. When that happens, surgical repair is almost always preferred over replacement — preserving your own tissue, better long-term heart function, and no lifelong blood thinners. For patients who aren't candidates for surgery, percutaneous edge-to-edge repair (MitraClip) offers real relief without opening the chest.

For patients in their 30s–50s who need valve replacement, newer mechanical valves — like the Onyx — require significantly less anticoagulation than older designs, making blood thinner management far more manageable for active, younger patients who want a lifetime solution.